On the afternoon of April 11, the “Stem Cell Clinical New Technology Application and Transformation Development Seminar” hosted by the editorial department of “Chongqing Medicine” and Academician Wang Zhengguo’s Workstation of Beike Biotech was successfully held. This conference brought together many experts, scholars, clinicians and industry representatives in the field of stem cells to discuss the latest progress, clinical applications and future development directions of stem cell technology. The meeting was chaired by Shi Yun, Director of the Editorial Department of “Chongqing Medicine”.
Conference site
Shi Yun, Director of the Editorial Department of “Chongqing Medicine”
Professor Cai Cheguo, professor of the Hangzhou Institute for Advanced Study at the University of Science and Technology of China and chief scientist of the Beike Biotechnology R&D Center, shared his scientific research results in the field of tissue regeneration and repair under the topic of “Clinical Application Research of Stem Cells and Construction and Application of Organoids”, such as the establishment of a three-dimensional culture and in vitro expansion system of breast stem cells under the influence of hormones, an organoid system for breast cancer, a co-culture system of breast stem cells and macrophages, and functional breast organoids with lactation function, which provided strategies and optimization for breast cancer targets and drug screening. Tan Liang, Dean of Beike Biotechnology Research Institute, introduced the clinical research progress of stem cells in multiple disciplines based on his own research direction. He applied stem cell therapy to nine major disease areas, including systemic lupus erythematosus, childhood cerebral palsy, type 2 diabetes, and decompensated cirrhosis, providing patients with new treatment options and highlighting the great potential of stem cell therapy in cell replacement, tissue repair, and disease treatment.
Professor Cai Cheguo, Professor of the Hangzhou Institute for Advanced Study of the University of Science and Technology of China and Chief Scientist of Beike Biotechnology R&D Center
Director Tan Liang, Beike Biotechnology Research Institute
The discussion stage of the meeting was chaired by Professor Zhang Bo from the Army Specialty Medical Center and Professor Shi Chunmeng from the Army Medical University. The participating experts discussed stem cell management practices, stem cell product preparation quality and safety evaluation, stem cell clinical research and cell product registration application, stem cell quality testing and evaluation, etc. to provide reasonable opinions and suggestions for the application and transformation development of new stem cell clinical technologies.
Hot discussion among the experts
With the rapid development of science and technology, stem cell clinical application research and organoid construction technology have gradually emerged in the medical field. These innovative technologies have brought new opportunities to the medical field and also provided new solutions for disease treatment and research. The convening of this conference has made efforts and explorations for in-depth research on stem cells and organoids and the development of regenerative medicine. “Chongqing Medicine” will continue to be committed to strengthening academic exchanges among industry peers, expanding cooperative research, and promoting the high-quality development of health scientific research.
Beike Biotechnology will also continue to increase its investment in the research and application of stem cell technology, actively cooperate and communicate with domestic and foreign counterparts, and jointly promote the innovation and development of stem cell technology, injecting new impetus into the clinical application and transformational development of stem cell technology.